Recent progress in structure-based anti-influenza drug design
about
A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutininNew small-molecule drug design strategies for fighting resistant influenza AThe influence of 150-cavity binders on the dynamics of influenza A neuraminidases as revealed by molecular dynamics simulations and combined clusteringIn vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis giganteaGenomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011Broad Spectrum Anti-Influenza Agents by Inhibiting Self-Association of Matrix Protein 1.Modeling the membrane environment has implications for membrane protein structure and function: influenza A M2 protein.Azapropellanes with anti-influenza a virus activity.Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication.In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination PotentialBeyond Structural Biology to Functional Biology: Solid-State NMR Experiments and Strategies for Understanding the M2 Proton Channel Conductance.Polyphylla saponin I has antiviral activity against influenza A virusIdentifying inter-residue resonances in crowded 2D (13)C- (13)C chemical shift correlation spectra of membrane proteins by solid-state MAS NMR difference spectroscopyAb initio calculations and validation of the pH-dependent structures of the His37-Trp41 quartet, the heart of acid activation and proton conductance in the M2 protein of Influenza A virusNew-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza.Quantitative structure-activity relationship: promising advances in drug discovery platforms.Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target.Synthesis and evaluation of influenza A viral neuraminidase candidate inhibitors based on a bicyclo[3.1.0]hexane scaffold.Isocyanides as Influenza A Virus Subtype H5N1 Wild-Type M2 Channel Inhibitors.Atypical group 1 neuraminidase pH1N1-N1 bound to a group 1 inhibitor.San Wu Huangqin Decoction, a Chinese Herbal Formula, Inhibits Influenza a/PR/8/34 (H1N1) Virus Infection In Vitro and In Vivo.
P2860
Q27676298-37DB8994-0603-449F-886A-F970765655BEQ28080554-BEC67B15-8636-45DC-A1AD-2A7D9385D55DQ28489068-69FC7097-11C7-45F0-8B8F-3F110B913F22Q28541723-5CEBD7B8-E2E0-4BEE-8A13-C23B2281D4A0Q30357267-E2C1E6F1-0FE4-4939-AFD8-C2CE97A7372EQ30392359-B78E0320-7447-4094-9BC6-9D729F57BB62Q30426896-06F9B654-B9CB-45A0-9D3E-F89EB5BDA89DQ33889072-8A40595E-735C-4653-A7B8-051AD9B3F0FCQ34721639-DA8861F4-FBCB-42B5-B818-C930C694AC19Q35982621-C86EC173-7153-49EA-96BB-243A179F3F51Q36351696-EA151CF0-E55B-4EF3-BBE5-756E60719117Q36412070-A933939E-8E38-4517-9875-8CDFF2619E8DQ37030264-CC3CBBA6-07B5-4C73-9058-AFEEC650EC30Q37069593-FF820685-25FD-47D1-BA6B-0003D6433BB3Q38128093-782690E8-BA58-4BF9-87FC-0DA89CE2D34DQ38384758-6ED2C548-D99B-49E7-9B2E-A18AD8B241EBQ38584487-3608122E-1F68-45EF-9B7C-CC5089A9F65AQ39152320-26B4AFBD-32C4-4DFB-A2B2-4BBA536F4658Q40699937-FE955663-E9FD-4523-8236-B0BAAA459068Q41180414-1F266FC6-2DA1-45A2-B553-643FF373F12EQ43229041-82254ACE-F28E-41A6-A55F-E8D958B579EFQ52664479-AF4429BE-3FBE-4E79-A3D4-0CCF31E510B1
P2860
Recent progress in structure-based anti-influenza drug design
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Recent progress in structure-based anti-influenza drug design
@ast
Recent progress in structure-based anti-influenza drug design
@en
Recent progress in structure-based anti-influenza drug design
@nl
type
label
Recent progress in structure-based anti-influenza drug design
@ast
Recent progress in structure-based anti-influenza drug design
@en
Recent progress in structure-based anti-influenza drug design
@nl
prefLabel
Recent progress in structure-based anti-influenza drug design
@ast
Recent progress in structure-based anti-influenza drug design
@en
Recent progress in structure-based anti-influenza drug design
@nl
P2860
P3181
P1433
P1476
Recent progress in structure-based anti-influenza drug design
@en
P2093
Timothy A Cross
P2860
P304
P3181
P356
10.1016/J.DRUDIS.2012.06.002
P407
P577
2012-06-13T00:00:00Z